Psoriasis and Atopic dermatitis
Study code: 18-502 Cohort 10 – £2,700
- People with moderate atopic dermatitis affecting 5-40% of the body needed for the study of a potential new treatment to help reduce the symptoms of inflammatory diseases such as psoriasis and atopic dermatitis (eczema). You must be aged 18 to 65 and have been diagnosed by your GP at least 6 months ago. The study involves a total 9 outpatient visits over 10 weeks. Groups starting from 26 July.